展品99.1
MEDIROm醫療科技公司宣布2024年8月。
主要績效指標(KPI)
總客戶服務數量: 83,771 – 每位客戶的銷售額: 日幣 7,144 – 客戶重複率: 75.1%
東京/2024年9月24日 – MEDIROm醫療科技公司(NasdaqCM: MRM),一家總部位於日本的整全保健公司(「公司」),今天宣布其重要的主要績效指標,或稱為KPI,已更新至2024年8月。提供了所有具有可比財務和客戶數據的沙龍的數據,並排除了某些沙龍,因為這些信息不可用。
美容院控制項業務
以下月度KPI提供了對公司業務基本面和進展的見解,已更新至2024年8月:
● | 美容院數量在2024年8月為307家,較去年同期的316家減少。 |
● | 2024年8月服務的客戶總數從去年同期的87,224人減少至83,771人。 |
● | 每位客戶銷售額從2024年8月的7,144日元增加至 在去年同期。 |
● | 重複比率,即重複客戶的衡量工具,在2024年8月從去年同期的74.6%稍微增加至75.1%。 |
● | 操作比率在2024年8月為47.3%,低於去年同期的48.0%。 |
● | 具備數據的沙龍總數為283家,在2024年8月下降至去年同期的291家。當公司關閉具有數據的沙龍並隨著公司開設具有該等數據的沙龍或升級現有沙龍的客戶管理系統以提供此類數據時,具有數據的沙龍數量會增加。 |
| 購回的股票數目 日幣 6,612(*1) | 購回的股票數目 一月-23 資料(*2) | (*3) | 客戶(*4) | 比率(*5) | 控制項比率(*6) |
八月-23 | 316 | 291 | 87,224 | | 74.6% | 48.0% |
九月-23 | 315 | 290 | 84,393 | | 76.7% | 47.0% |
十月-23 | 315 | 291 | 82,249 | Number of Salons: Includes the Company’s directly-operated salons and franchisees’ salons. | 77.4% | 45.4% |
十一月-23 | 313 | 289 | 75,290 | 日元 7,045 | 77.5% | 43.9% |
12月23日 | 314 | 290 | 83,124 | JPY 7,271 | 77.7% | 46.7% |
1月24日 | 311 | 287 | 74,533 | JPY 7,147 | 76.8% | 44.7% |
二月-24 | 311 | 287 | 71,376 | 日圓 7,099 | 77.6% | 44.9% |
三月二十四日 | 312 | 288 | 77,854 | 日圓 7,190 | 77.9% | 45.7% |
四月二十四日 | 308 | 285 | 74,621 | 日圓 7,143 | 75.9% | 43.5% |
五月-24 | 307 | 284 | 80,512 | 日本6,964 | 74.8% | 44.9% |
六月-24 | 308 | 285 | 82,656 | 日本7,061 | 75.6% | 47.4% |
七月-24 | 309 | 286 | 81,580 | 日本7,060 | 75.0% | 46.6% |
八月-24 | 307 | 283 | 83,771 | 日本7,144 | 75.1% | 47.3% |
(*1) | 沙龍數量:包括公司直營沙龍和特許經營沙龍。 |
(*2) | 有數據的沙龍數量:具有可比較的財務和客戶數據的沙龍數目。 |
(*3) | 已服務顧客總數:可提供可比財務和客戶數據的沙龍所服務的顧客數量。 |
(*4) | 每位顧客的銷售額:所有提供可比財務和客戶數據的美容院的總銷售額與接受服務的顧客數量的比率。 |
(*5) | 重複比率:适用月份内所有提供可比財務和客戶數據的美容院的重複顧客訪問次數與總顧客訪問次數的比率。 |
(*6) | 操作比率:適用月份内所有提供可比財務和客戶數據的美容院中治療師在職時間與總治療師工作時間(包括待命時間)的比率。 |
2
* Repeat ratios shown in the chart above do not include salons in public bath houses. In August 2024, the repeat ratios for all salons and salons in public bathhouses only were 75.1% and 55.1%, respectively.
3
*Since July 2021, the salon operation business has been managed by Wing Inc., which is a wholly-owned subsidiary of the Company.
Health Tech Business (Lav®)
The Company offers a government-specific health guidance program (the “Program”) using Lav®, an on-demand training application developed by the Company. The Program is designed to be less burdensome for the users and is delivered through a completely remote support style using the web remote interview and chat function of Lav®. This approach helps to reduce the dropout rate of conventional specific health guidance programs.
The Program provides support to medical professionals, such as public health nurses, dietitians, etc., that assist eligible individuals (age between 40 and 74) who are at risk of developing lifestyle-related diseases that can be caused by an unbalanced diet, lack of sleep, lack of exercise, smoking, stress, and other factors, by reviewing their lifestyle habits through specific health checkups that focus on metabolic syndrome. The implementation of specific health checkups and specific health guidance has become mandatory for medical insurers in Japan, including national health insurance and employee health insurance providers, since April 2008.
The Ministry of Health, Labor and Welfare has set a nationwide target of at least 70% for specific medical checkup implementation rates and at least 45% for specific health guidance implementation rates. In fiscal year 2021, however, the medical checkup implementation rates and specific health guidance implementation rates were only 56.5% and 24.6%, respectively. As a result, the market for these services is expected to expand due to the government’s effort to achieve the set target implementation rates. According to a survey by the Japan Health Guidance Association, the utilization of Information and Communication Technology (ICT) has been increasing, and the adoption rate has exceeded 50% due to the impact of COVID-19 in recent years.
4
As of August 2024, the Company has entered into contracts with 87 corporate insurance associations, and the cumulative number of users of the Company’s Lav® app has exceeded 7,000 people, bringing the total to 7,644 individuals.
| Number of New Contracts with Corporate Insurance Associations(*1) | Number of New Users(*2) | Cumulative Number of Contracts with Corporate Insurance Associations(*3) | Cumulative Number of Users |
August-23 | 0 | 100 | 69 | 5,534 |
September-23 | 2 | 179 | 71 | 5,713 |
October-23 | 1 | 293 | 72 | 6,006 |
November-23 | 1 | 256 | 73 | 6,262 |
December-23 | 1 | 161 | 74 | 6,423 |
January-24 | 1 | 174 | 75 | 6,597 |
February-24 | 1 | 152 | 76 | 6,749 |
March-24 | 1 | 203 | 76 | 6,952 |
April-24 | 3 | 187 | 79 | 7,139 |
May-24 | 2 | 99 | 81 | 7,238 |
June-24 | 2 | 131 | 83 | 7,369 |
July-24 | 1 | 166 | 84 | 7,535 |
August-24 | 3 | 109 | 87 | 7,644 |
(*1) | Number of new contracts with corporate insurance associations entered into in the applicable month to implement specified health guidance program offered by the Company. |
(*2) | Number of new users that started using specified health guidance offered by the Company in the applicable month. |
(*3) | Cumulative number of contracts with corporate insurance associations excluding the number of terminated contracts. |
5
Forward-Looking Statements
Certain statements in this press release are forward-looking statements for purposes of the safe harbor provisions under the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements may include estimates or expectations about the Company’s possible or assumed operational results, financial condition, business strategies and plans, market opportunities, competitive position, industry environment, and potential growth opportunities. In some cases, forward-looking statements can be identified by terms such as “may,” “will,” “should,” “design,” “target,” “aim,” “hope,” “expect,” “could,” “intend,” “plan,” “anticipate,” “estimate,” “believe,” “continue,” “predict,” “project,” “potential,” “goal,” or other words that convey the uncertainty of future events or outcomes. These statements relate to future events or to the Company’s future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause the Company’s actual results, levels of activity, performance, or achievements to be different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements because they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond the Company’s control and which could, and likely will, affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects the Company’s current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to the Company’s operations, results of operations, growth strategy and liquidity. Some of the factors that could cause actual results to differ materially from those expressed or implied by the forward-looking statements in this press release include:
● | the Company’s ability to achieve its development goals for its business and execute and evolve its growth strategies, priorities and initiatives; |
● | the Company’s ability to sell certain of its owned salons to investors, and receive management fees from such sold salons, on acceptable terms; |
● | changes in Japanese and global economic conditions and financial markets, including their effects on the Company’s expansion in Japan and certain overseas markets; |
● | the Company’s ability to achieve and sustain profitability in its Digital Preventative Healthcare Segment; |
● | the fluctuation of foreign exchange rates, which affects the Company’s expenses and liabilities payable in foreign currencies; |
● | the Company’s ability to hire and train a sufficient number of therapists and place them at salons in need of additional staffing; |
● | changes in demographic, unemployment, economic, regulatory or weather conditions affecting the Tokyo region of Japan, where the Company’s relaxation salon base is geographically concentrated; |
6
● | the Company’s ability to maintain and enhance the value of its brands and to enforce and maintain its trademarks and protect its other intellectual property; |
● | the financial performance of the Company’s franchisees and the Company’s limited control with respect to their operations; |
● | the Company’s ability to raise additional capital on acceptable terms or at all; |
● | the Company’s level of indebtedness and potential restrictions on the Company under the Company’s debt instruments; |
● | changes in consumer preferences and the Company’s competitive environment; |
● | the Company’s ability to respond to natural disasters, such as earthquakes and tsunamis, and to global pandemics, such as COVID-19; and |
● | the regulatory environment in which the Company operates. |
More information on these risks and other potential factors that could affect the Company’s business, reputation, results of operations, financial condition, and stock price is included in the Company’s filings with the Securities and Exchange Commission (the “SEC”), including in the “Risk Factors” and “Operating and Financial Review and Prospects” sections of the Company’s most recently filed periodic report on Form 20-F and subsequent filings, which are available on the SEC website at www.sec.gov. The Company assumes no obligation to update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ from those anticipated in these forward-looking statements, even if new information becomes available in the future.
About MEDIROM Healthcare Technologies Inc.
MEDIROM, a holistic healthcare company, operates 307 (as of August 31, 2024) relaxation salons across Japan, Re.Ra.Ku® being its leading brand, and provides healthcare services. In 2015, MEDIROM entered the health tech business and launched new healthcare programs using an on-demand training app called “Lav®”, which is developed by the Company. MEDIROM also entered the device business in 2020 and has developed a smart tracker “MOTHER Bracelet®”. In 2023, MEDIROM launched REMONY, a remote monitoring system for corporate clients, and has received orders from a broad range of industries, including nursing care, transportation, construction, and manufacturing, among others. MEDIROM hopes that its diverse health-related product and service offerings will help it collect and manage healthcare data from users and customers and enable it to become a leader in big data in the healthcare industry. For more information, visit https://medirom.co.jp/en.
■Contacts
Investor Relations Team
ir@medirom.co.jp
7